Institut Curie
LightNews LightNews
banner
institutcurie.bsky.social
Institut Curie
@institutcurie.bsky.social
2.9K followers 60 following 160 posts
🌐 Internationally renowned #Research Center
🏥 State-of-the-art Hospital Group
🇨🇵 France's leading #cancer center
curie.fr
Posts Replies Media Videos
institutcurie.bsky.social
🥦 Could nutrition boost the efficacy of immunotherapy? A study led by Dr. Elodie Segura (@institutcurie.bsky.social / @inserm.fr) published in @nature.com communication shows that indole-3-carbinol from cruciferous vegetables is essential for anti-PD1 efficacy in preclinical models.
December 3, 2025 at 2:14 PM
institutcurie.bsky.social
Contre les métastases et les rechutes, la lutte contre le #cancer progresse : dans les laboratoires de l'Institut Curie, la compréhension des mécanismes de cancérisation permet d’inventer les armes du futur contre les tumeurs. À la une de l'Express cette semaine ▶️ www.lexpress.fr/sciences-san...
November 27, 2025 at 3:29 PM
institutcurie.bsky.social
👏 Félicitations au Dr Enzo Poirier, chargé de recherche @inserm.fr et chef d'équipe à l’Institut Curie qui a reçu le prix de la Fondation Joannidès de l'@academiesciences.bsky.social, saluant ses travaux de recherche sur l'immunité innée.
November 26, 2025 at 4:21 PM
institutcurie.bsky.social
👏 Félicitations au Dr Gudrun Schleiermacher, pédiatre oncologue à l’Institut Curie distinguée par l'@academiesciences.bsky.social par la médaille de Biologie humaine et sciences médicales pour ses travaux sur les mécanismes moléculaires des cancers pédiatriques et leur résistance aux traitements.
November 26, 2025 at 4:21 PM
institutcurie.bsky.social
Entre cartographie d'une terre inconnue et édition génétique, Têtes Chercheuse part aujourd'hui à la rencontre d'Antonin Morillon(@institutcurie.bsky.social/@cnrs.fr) qui nous dévoile ses travaux sur le "dark génome" et leur application face aux cancers.

▶️ curie.fr/actualite/po...
November 25, 2025 at 10:53 AM
institutcurie.bsky.social
A study recently published in The Lancet Regional Health – Europe shows the impact of the French national multidisciplinary tumour board coordinated by @institutcurie.bsky.social with a demonstrated survival benefit for patients with cancer of unknown primary: www.thelancet.com/journals/lan...
November 13, 2025 at 3:02 PM
institutcurie.bsky.social
📣 Discovery of a cellular resistance mechanism at the origin of relapses of triple-negative breast cancer: an essential step on the path towards more preventive medicine that is able to anticipate and avoid relapses.

▶️ institut-curie.org/news/relapse...
November 12, 2025 at 11:00 AM
institutcurie.bsky.social
🎙️ Dans le bureau-jardin du Dr Manuel Rodrigues, littérature, botanique et science se rencontrent pour raconter une même histoire : celle des signatures de l’ADN, ces empreintes qui révèlent l’origine de certaines tumeurs.

Nouvel épisode de Têtes Chercheuses, à écouter sur : curie.fr/actualite/po...
November 12, 2025 at 9:49 AM
institutcurie.bsky.social
🔈New crop of #ERC Synergy Grants for Institut Curie!
3 projects involving our researchers are on the list of winners of ERC Synergy Grants 2025: Nicolas Manel, Daniele Fachinetti, Stéphanie Descroix, Alexandre Baffet, Benoît Sorre, Leonid Mirny
➡️Learn more: institut-curie.org/news/new-cro...
#ERCSyG
November 10, 2025 at 4:43 PM
institutcurie.bsky.social
👏 Double success for @institutcurie.bsky.social & @minesparis-psl.bsky.social at MIDOG 2025: Prof. @thomas-walter.bsky.social team ranks 1st in mitosis classification and 2nd in detection, standing out among the leading groups in artificial intelligence applied to medical image analysis.
October 30, 2025 at 3:07 PM
institutcurie.bsky.social
🎧 Nouvelle saison de Têtes Chercheuses !

Sarah Watson, oncologue et chercheuse à l’Institut Curie, est spécialiste des cancers rares. Au micro de Zoé Varier, elle raconte la complexité de ces maladies et la dimension humaine qui la guide.

🎙️ À écouter dès maintenant : curie.fr/actualite/po...
October 28, 2025 at 10:22 AM
institutcurie.bsky.social
📣 Registration for the next international course at
@institutcurie.bsky.social on the innovative approaches for pediatric cancer immunotherapy is now open, until november 28th, 2025.

🗓️ January 28 - 30, 2026
▶️ More info: training.institut-curie.org/courses/inno...
October 23, 2025 at 10:19 AM
institutcurie.bsky.social
⏳ Last days to register to the Development & Cancer course at @institutcurie.bsky.social! Discover the current knowledge linking developmental biology with the cellular and molecular study of cancers with international experts.

Register now ▶️ training.institut-curie.org/courses/deve...
October 22, 2025 at 9:21 AM
institutcurie.bsky.social
🎙️ Le podcast de l'Institut Curie est de retour pour une deuxième saison ! RDV le 28 octobre pour 6 nouveaux épisodes qui vous feront plonger dans les laboratoires de l’Institut Curie et découvrir la science autrement. 👀
October 21, 2025 at 2:32 PM
institutcurie.bsky.social
Registration for the next international course at @institutcurie.bsky.social is open, until november 14th. This 2nd edition will focus on understanding the molecular basis of urothelial tumors to improve diagnosis and treatment.

📅 January 14-16, 2026
▶️ training.institut-curie.org/courses/urot...
October 21, 2025 at 10:09 AM
institutcurie.bsky.social
#ESMO25 | Studies of the French national coordination on unknown primary cancers (CUP) led by Institut Curie show the importance of a collaborative and multidisciplinary approach to improve targeted treatments in these rare cancers.

Learn more:
➡️ institut-curie.org/esmo2025

#OncSky #CUP
October 20, 2025 at 4:46 PM
institutcurie.bsky.social
#ESMO25 | New insights from the IMMUNOBIL phase II trial presented by Dr Matthieu Delaye (Institut Curie): a combination of 2 immunotherapies in advanced biliary tract cancer after platinum-based chemo shows promising survival for a subgroup of patients.

➡️ institut-curie.org/esmo2025
October 20, 2025 at 2:27 PM
institutcurie.bsky.social
#ESMO25 | Physicians and researchers from @institutcurie.bsky.social delighted to share their latest advances, innovations, and expertise to accelerate discoveries in #oncology for the benefit of patients 🤝

Learn more:
📍https://institut-curie.org/esmo2025
📍Booth Institut Curie / Hall 2.2b - #2036
October 20, 2025 at 9:59 AM
institutcurie.bsky.social
#ESMO25 | New insights from the SOHO-01 study presented by Prof. NIcolas Girard @institutcurie.bsky.social:
Molecular factors and ctDNA dynamics may help predict outcomes in patients with HER2-mutant #NSCLC treated with sevabertinib, paving the way for more personalized care.

#medonc #lungcancer
October 19, 2025 at 1:13 PM
institutcurie.bsky.social
#ESMO25 | Uveal melanoma: positive results of the phase 2 PLUME clinical trial, presented by Dr. Manuel Rodrigues @institutcurie.bsky.social (efficacy and tolerability of immunotherapy anti-PD-1 + targeted treatment)

➡️ Learn more:
institut-curie.org/news/metasta...
#medonc #oncalert
October 18, 2025 at 4:56 PM
institutcurie.bsky.social
#ESMO25 | Promising real-world data from the french multicenter LARENA study presented by Dr Diana Bello-Roufai @institutcurie.bsky.social, show that adapting pembrolizumab-lenvatinib dosing in metastatic endometrial cancer reduces toxicity without compromising efficacy.

#medonc
October 18, 2025 at 11:50 AM
institutcurie.bsky.social
#ESMO2025 | Finding Less Toxic Treatments for Women with Hormone-Dependent #BreastCancer.
Pr Paul Cottu (Institut Curie) presented preliminary results from the RIBOLARIS study, showing that in 52% of pts, chemotherapy could be replaced with a less toxic treatment
👉 institut-curie.org/news/less-to...
October 17, 2025 at 2:35 PM
institutcurie.bsky.social
📍 Expert scientists and clinicians of Institut Curie are attending #ESMO25, Europe’s key #oncology congress.
They’ll share promising results in breast cancer, uveal melanoma, cancers of unknown origin, and new therapeutic innovations for patients.
👉 institut-curie.org/esmo2025 @myesmo.bsky.social
October 17, 2025 at 2:22 PM
institutcurie.bsky.social
Registration is open for the next Genome Dynamics course at @institutcurie.bsky.social! This course will explore the full spectrum of genome biology bringing together international experts to share the latest experimental and computational advances ▶️ training.institut-curie.org/courses/Geno...
October 14, 2025 at 9:14 AM
institutcurie.bsky.social
A key mechanism behind Mycobacterium tuberculosis survival:
Researchers, including Dr. Ting-Di Wu from Institut Curie, found that the bacterium depends on a unique sulfate transporter — a potential target for new treatments without side effects on human cells.

🔗 www.pnas.org/doi/abs/10.1...
October 7, 2025 at 2:24 PM